ATE361066T1 - Polyungesättigen fettsäuren nährungsergänzung - Google Patents

Polyungesättigen fettsäuren nährungsergänzung

Info

Publication number: ATE361066T1
Authority: AT; Austria
Prior art keywords: ara; dha; polyunsaturated fatty; fatty acid; nutritional supplement
Prior art date: 1998-10-15

Application number

AT99970319T

Other languages

English (en)

Inventor

Waterschoot Isabel Antonia Van

Hugo Streekstra

Original Assignee

Dsm Ip Assets Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-15

Filing date

1999-10-15

Publication date

2007-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235104&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE361066(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-15 Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE361066T1 publication Critical patent/ATE361066T1/de

Links

235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract 4
235000015872 dietary supplement Nutrition 0.000 title abstract 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 18
229940114079 arachidonic acid Drugs 0.000 abstract 9
235000021342 arachidonic acid Nutrition 0.000 abstract 9
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 8
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 5
229940090949 docosahexaenoic acid Drugs 0.000 abstract 4
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Polymers & Plastics (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Food Science & Technology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Immunology (AREA)
Animal Husbandry (AREA)
Mycology (AREA)
Pregnancy & Childbirth (AREA)
Zoology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Rheumatology (AREA)
Hematology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gynecology & Obstetrics (AREA)
Psychology (AREA)

AT99970319T 1998-10-15 1999-10-15 Polyungesättigen fettsäuren nährungsergänzung ATE361066T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98308403		1998-10-15

Publications (1)

Publication Number	Publication Date
ATE361066T1 true ATE361066T1 (de)	2007-05-15

Family

ID=8235104

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99970319T ATE361066T1 (de)	1998-10-15	1999-10-15	Polyungesättigen fettsäuren nährungsergänzung

Country Status (13)

Country	Link
US (2)	US20070184090A1 (de)
EP (4)	EP2292223A1 (de)
JP (2)	JP2002527387A (de)
CN (3)	CN102090636A (de)
AT (1)	ATE361066T1 (de)
AU (2)	AU775421B2 (de)
CA (2)	CA2653503A1 (de)
DE (1)	DE69935995T3 (de)
DK (1)	DK1121115T4 (de)
ES (1)	ES2284286T5 (de)
HK (1)	HK1042441A1 (de)
NZ (1)	NZ511071A (de)
WO (1)	WO2000021524A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0016045D0 (en)	2000-06-29	2000-08-23	Laxdale Limited	Therapeutic combinations of fatty acids
CN101845446B (zh)	2000-09-28	2016-01-20	生物源食物及科学公司	脂肪酸去饱和酶家族成员fad4、fad5、fad5-2和fad6及它们的应用
EP1380293A4 (de) *	2001-03-30	2009-03-18	Nisshin Oillio Group Ltd	Mittel zur verbesserung des knochenstoffwechsels
JP2003048831A (ja)	2001-08-02	2003-02-21	Suntory Ltd	脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
AU778384B2 (en) *	2001-11-14	2004-12-02	Virtus Nutrition Llc	Method for manufacturing fatty acid calcium salts from high glyceride content oils
AU2003245978A1 (en) *	2002-06-19	2004-01-06	Dsm Ip Assets B.V.	Pasteurisation process for microbial cells and microbial oil
JP4771697B2 (ja) *	2002-09-24	2011-09-14	サントリーホールディングス株式会社	認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
US20070037885A1 (en) *	2003-04-25	2007-02-15	Sandra Edwards	Biomass containing animal feed
US8633247B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Method for decreasing cartilage damage in dogs
US8633246B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Omega-3 fatty acids for osteoarthritis
CA2569230C (en)	2004-04-30	2014-12-02	Nutriscience Technology, Inc.	Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
CN1997425B (zh) *	2004-07-01	2010-10-13	雀巢技术公司	犬骨关节炎饮食配方
ES2253089B1 (es) *	2004-07-16	2007-08-16	Berthol Victor Laboratorios Ordesa, S.L.	Complemento nutraceutico para la preparacion de leches infantiles.
JP2006083136A (ja) *	2004-09-17	2006-03-30	Suntory Ltd	ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP4993852B2 (ja)	2004-09-17	2012-08-08	サントリーホールディングス株式会社	ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja)	2005-06-30	2016-08-10	サントリーホールディングス株式会社	日中活動量の低下および／又はうつ症状の改善作用を有する組成物
EP1772146A1 (de) *	2005-10-03	2007-04-11	Neuropharma, S.A.	Merfach ungesättigte Fettsäuren als BACE-Inhibitoren
EP2098229A4 (de)	2006-12-28	2010-03-10	Suntory Holdings Ltd	Nervenregenerationsmittel
WO2009102558A2 (en) *	2008-02-11	2009-08-20	Monsanto Technology Llc	Aquaculture feed, products, and methods comprising beneficial fatty acids
CN101259101B (zh) *	2008-04-17	2010-06-02	湖北福星生物科技有限公司	微米级花生四烯酸和二十二碳六烯酸乳状液及其制备方法
GB2460056A (en) *	2008-05-14	2009-11-18	Arab Science & Technology Foun	Compositions comprising omega-6 fatty acids for use in treating schistosomiasis
US10052299B2 (en)	2009-10-30	2018-08-21	Retrotope, Inc.	Alleviating oxidative stress disorders with PUFA derivatives
JP6145087B2 (ja)	2011-04-26	2017-06-07	レトロトップ、インコーポレイテッドＲｅｔｒｏｔｏｐｅ，Ｉｎｃ．	Ｐｕｆａ酸化関与障害
JP6106157B2 (ja)	2011-04-26	2017-03-29	レトロトップ、インコーポレイテッドＲｅｔｒｏｔｏｐｅ，Ｉｎｃ．	神経変性障害および筋疾患に関与するｐｕｆａ
WO2012148930A2 (en) *	2011-04-26	2012-11-01	Retrotope, Inc.	Oxidative retinal diseases
KR102112087B1 (ko)	2011-04-26	2020-05-18	레트로토프 인코포레이티드	에너지 프로세싱 손상 장애 및 미토콘드리아 결함
EP2745706A1 (de) *	2012-12-24	2014-06-25	Abbott Laboratories, Inc.	Verfahren zur Aufrechterhaltung der Knochenqualität
KR102416853B1 (ko)	2013-12-20	2022-07-05	마라 리뉴어블즈 코퍼레이션	미생물로부터 오일을 회수하는 방법
MA41611A (fr) *	2015-02-23	2018-01-02	Omthera Pharmaceuticals Inc	Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
EP3950649A1 (de)	2015-11-23	2022-02-09	Retrotope, Inc.	Ortsspezifische isotopische markierung von 1,4-dien-systemen
US10851395B2 (en)	2016-06-10	2020-12-01	MARA Renewables Corporation	Method of making lipids with improved cold flow properties
EP3559206B1 (de)	2016-12-22	2025-12-03	Mara Renewables Corporation	Verfahren zur herstellung von biomasse mit hohem gehalt an dha, palmitäure und protein unter verwendung eines eukaryotischen mikroorganismus
IL295783B2 (en)	2020-02-21	2026-03-01	Retrotope Inc	Processes for isotopic alteration of polyunsaturated fatty acids and their derivatives
KR20220163979A (ko)	2020-04-03	2022-12-12	마라 리뉴어블즈 코퍼레이션	높은 수준의 오메가-3 지방산을 갖는 미생물 오일
US12109194B2 (en)	2021-02-05	2024-10-08	Biojiva Llc	Synergistic combination therapy for treating ALS
EP4583720A1 (de) *	2022-09-07	2025-07-16	Nourish Ingredients Pty Ltd	Zusammensetzungen und verfahren zur herstellung fleischähnlicher aromen
WO2026020071A1 (en) *	2024-07-18	2026-01-22	Red Abbey Labs, Llc	Autogenous therapeutic lipid carriers

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8916734D0 (en) *	1989-07-21	1989-09-06	Efamol Holdings	Pharmaceutical and dietary uses of fatty acids
CA2101274C (en) *	1991-01-24	1998-12-15	David J. Kyle	Microbial oil mixtures and uses thereof
PH11992043811B1 (en) *	1991-01-24	2002-08-22	Martek Corp	Arachidonic acid and methods for the production and use thereof
US5658767A (en) †	1991-01-24	1997-08-19	Martek Corporation	Arachidonic acid and methods for the production and use thereof
JPH0692848A (ja) *	1992-09-11	1994-04-05	Sagami Chem Res Center	糖尿病治療用乳剤
GB9224809D0 (en) *	1992-11-26	1993-01-13	Scotia Holdings Plc	Schizophrenia
JPH06271464A (ja) *	1993-03-19	1994-09-27	Tokiwa Yakuhin Kogyo Kk	消化器系障害の予防または治療用アラキドン酸含有組成物
CA2164291C (en) *	1993-06-09	2007-10-30	David John Kyle	Methods and pharmaceutical compositions useful for treating neurological disorders
JPH07267856A (ja) *	1994-02-09	1995-10-17	Green Cross Corp:The	経口免疫抑制剤
GB9510636D0 (en) *	1995-05-25	1995-07-19	Scotia Holdings Plc	Fatty acid treatment
EP1886679A3 (de) *	1995-06-07	2008-05-28	Martek Biosciences Corporation	Verfahren zur Regulierung des Gehalts an mehrfach ungesättigten Fettsäuren in verschiedenen Geweben
US6200624B1 (en)	1996-01-26	2001-03-13	Abbott Laboratories	Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
ES2177966T3 (es)	1996-03-26	2002-12-16	Dsm Nv	Particulas de vehiculos solidos revestidas con acidos grasos poliinsaturados (pufa) para productos alimentarios.
ES2256882T5 (es)	1996-03-26	2012-12-17	Dsm Ip Assets B.V.	Agregado tardío de pufa en el transcurso del proceso de preparación de una leche maternizada
ATE328104T1 (de)	1996-03-28	2006-06-15	Dsm Ip Assets Bv	Mikrobielles polyungesättigte fettsäure enthaltendes öl und verfahren zur herstellung eines öls aus pasteurisierter und granulierter biomasse
WO1997036996A2 (en)	1996-03-28	1997-10-09	Gist-Brocades B.V.	Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
FR2749133A1 (fr) *	1996-06-04	1997-12-05	Pierre Moreau	Obtention d'oeufs specifiquement enrichis en acide cervonique (acide docosahexaenoique ou dha). applications alimentaires, therapeutiques et industrielles de ces oeufs et de leurs extraits lipidiques
JP3792309B2 (ja) *	1996-08-30	2006-07-05	サントリー株式会社	不飽和脂肪酸含有油脂の製造方法
JP4633204B2 (ja) *	1996-10-11	2011-02-16	サントリーホールディングス株式会社	アラキドン酸含有食用油脂およびそれを含有する食品

1999
- 1999-10-15 AT AT99970319T patent/ATE361066T1/de not_active IP Right Cessation
- 1999-10-15 DK DK99970319.2T patent/DK1121115T4/da active
- 1999-10-15 HK HK02104290.7A patent/HK1042441A1/zh unknown
- 1999-10-15 EP EP10174886A patent/EP2292223A1/de not_active Withdrawn
- 1999-10-15 ES ES99970319T patent/ES2284286T5/es not_active Expired - Lifetime
- 1999-10-15 WO PCT/EP1999/007834 patent/WO2000021524A1/en not_active Ceased
- 1999-10-15 CN CN2010105804595A patent/CN102090636A/zh active Pending
- 1999-10-15 CA CA002653503A patent/CA2653503A1/en not_active Abandoned
- 1999-10-15 AU AU11520/00A patent/AU775421B2/en not_active Ceased
- 1999-10-15 EP EP07001289A patent/EP1803451A1/de not_active Withdrawn
- 1999-10-15 DE DE69935995T patent/DE69935995T3/de not_active Expired - Lifetime
- 1999-10-15 CN CNA2008100998281A patent/CN101283807A/zh active Pending
- 1999-10-15 NZ NZ511071A patent/NZ511071A/en not_active IP Right Cessation
- 1999-10-15 JP JP2000575500A patent/JP2002527387A/ja active Pending
- 1999-10-15 EP EP99970319A patent/EP1121115B2/de not_active Expired - Lifetime
- 1999-10-15 CN CN99813303A patent/CN1326344A/zh active Pending
- 1999-10-15 CA CA002355341A patent/CA2355341C/en not_active Expired - Fee Related
- 1999-10-15 EP EP10174874A patent/EP2308486A1/de not_active Withdrawn
2004
- 2004-10-28 AU AU2004224924A patent/AU2004224924B2/en not_active Ceased
2007
- 2007-03-20 US US11/711,086 patent/US20070184090A1/en not_active Abandoned
2008
- 2008-12-18 US US12/337,969 patent/US20090105342A1/en not_active Abandoned
2010
- 2010-12-01 JP JP2010268487A patent/JP2011098966A/ja active Pending

Also Published As

Publication number	Publication date
CN102090636A (zh)	2011-06-15
DE69935995T3 (de)	2011-02-10
DK1121115T3 (da)	2007-07-02
CA2355341C (en)	2009-04-14
CN101283807A (zh)	2008-10-15
CA2355341A1 (en)	2000-04-20
JP2011098966A (ja)	2011-05-19
DK1121115T4 (da)	2011-01-10
NZ511071A (en)	2004-01-30
EP1121115B2 (de)	2010-08-18
AU2004224924A1 (en)	2004-11-25
AU2004224924B2 (en)	2008-02-28
ES2284286T5 (es)	2011-01-03
WO2000021524A1 (en)	2000-04-20
US20070184090A1 (en)	2007-08-09
JP2002527387A (ja)	2002-08-27
HK1042441A1 (zh)	2002-08-16
CN1326344A (zh)	2001-12-12
DE69935995D1 (de)	2007-06-14
EP2292223A1 (de)	2011-03-09
ES2284286T3 (es)	2007-11-01
EP1121115A1 (de)	2001-08-08
CA2653503A1 (en)	2000-04-20
EP1121115B1 (de)	2007-05-02
DE69935995T2 (de)	2008-01-10
AU775421B2 (en)	2004-07-29
EP1803451A1 (de)	2007-07-04
US20090105342A1 (en)	2009-04-23
EP2308486A1 (de)	2011-04-13
AU1152000A (en)	2000-05-01

Legal Events

Date	Code	Title	Description
2007-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE361066T1 (de)	2007-05-15	Polyungesättigen fettsäuren nährungsergänzung
US5198468A (en)	1993-03-30	Essential fatty acid composition
EP0347056B1 (de)	1993-04-07	Zusammensetzungen essentieller Fettsäuren
US5562913A (en)	1996-10-08	Formulation for use in smokers
CA2069600C (en)	2004-05-04	Fatty acid compositions
TW200744463A (en)	2007-12-16	Nutritional supplement containing long-chain polyunsaturated fatty acids
NZ505608A (en)	2002-12-20	Fat blend
KR900008958A (ko)	1990-07-02	유아용 규정식품에 사용하기 위한 랜덤화된 야자유 지방 조성물
KR940018091A (ko)	1994-08-16	불포화 지방산을 포함하는 처방
CA1310911C (en)	1992-12-01	Essential fatty acid compositions
IT8423086A1 (it)	1986-04-10	Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
EP1211305A4 (de)	2002-11-13	Fettzusammensetzungen
SG143274A1 (en)	2008-06-27	Nutrition containing fat blend
EP0437524B1 (de)	1992-04-15	Triglyceride und nahrungszusammensetzung, die diese enthält
DK1027831T3 (da)	2006-02-20	Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
KR100270622B1 (ko)	2000-11-01	영양보급용 영양 조성물
EP0211502A2 (de)	1987-02-25	Verwendung von Linol- oder Linolensäure-Metaboliten zur Behandlung vom prämenstruellen Syndrom
CN1212867A (zh)	1999-04-07	防治心脑血管疾病的组合物